In the US, Nalmefene (nalmefene systemic) is a member of the drug class antidotes and is used to treat Opioid Overdose and Reversal of Opioid Sedation.
US matches:
- Nalmefene
- Nalmefene Hydrochloride
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0055096-26-9
Chemical Formula
C21-H25-N-O3
Molecular Weight
339
Therapeutic Category
Opioid receptor antagonist
Chemical Name
Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5α)-
Foreign Names
- Nalmefenum (Latin)
- Nalmefen (German)
- Nalmefene (French)
- Nalmefeno (Spanish)
Generic Names
- Nalmefene (OS: BAN, USAN)
- JF 1 (IS: Key)
- Nalmetrene (IS)
- ORF 11676 (IS)
- Nalmefene Hydrochloride (OS: BANM)
Brand Name
- Revex
Baxter, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.